ECG Ventricular Hypertrophy

Definition

ECG ventricular hypertrophy criteria are voltage- and morphology-based rules for identifying increased ventricular muscle mass from the surface 12-lead ECG. LVH criteria have consistently low sensitivity (<50%) but high specificity (85–90%); no single criterion is superior to the others, and different criteria identify different patient subgroups. RVH criteria perform similarly, with the best accuracy in congenital heart disease and the worst in COPD. Atrial P-wave abnormalities are a complementary ECG domain reflecting atrial enlargement, conduction delay, and elevated atrial pressure.

Key Concepts

Left Ventricular Hypertrophy — General Performance

• Sensitivity of all QRS voltage criteria: generally <50% (often 25–35%); specificity: 85–90%
• No single criterion is superior; criteria identify partially overlapping subgroups — in mild-moderate hypertension, only 11.2% of patients met both Sokolow-Lyon AND Cornell criteria
• Multiple validated criteria should be applied; automated ECG reports must specify which criteria were examined and which were abnormal
• Criteria apply reliably to adults >35 years; accuracy low in 16–35 year-olds and athletes
• (sources/ecg-chambers-aha-2009, rating: high)

LVH — Major Voltage Criteria

Limb lead criteria:

• Lewis: (R I − S I) + (S III − R III) ≥16 mm
• Gubner: R I + S III ≥25 mm; R I ≥15 mm
• R aVL ≥11 mm (Sokolow); R aVF ≥20 mm

Precordial criteria:

• Sokolow-Lyon (1949, most widely used): S V1 + R V5 (or R V6) ≥35 mm
• S V2 + R V5,6 ≥45 mm (Romhilt); S V1,2 + R V5,6 ≥35 mm (Murphy)

Combined criteria:

• Cornell voltage (1985, gender-adjusted): S V3 + R aVL ≥28 mm (men) / ≥20 mm (women)
• Cornell voltage-duration product: (S V3 + R aVL) × QRS duration ≥2,436 mm·ms (Molloy)
• Total 12-lead voltage × QRS duration ≥1,742 mm·ms

Point score system:

• Romhilt-Estes score (1968): Combines QRS voltage, axis, duration, R-peak time, P-wave morphology, and ST-T changes; threshold for LVH = 5 points

Criteria in the presence of conduction disorders:

• Left anterior fascicular block: S V1,2 + R V6 + S V6 ≥25 mm; S V1 + R V5 + S V5 ≥25 mm; S III + max R/S any lead ≥30 mm (men) / ≥28 mm (women)
• RBBB: S V1 >2 mm; R V5,6 >15 mm; R I ≥11 mm; S III + max R/S precordial >40 mm (with LAD); sensitivity 46–68%, specificity 57–71%

(sources/ecg-chambers-aha-2009, rating: high)

LVH — Confounding Factors

• Age: QRS voltages decline with age; criteria for 16–35-year-olds are poorly established; standard thresholds unreliable in young adults
• Sex: Women have slightly lower upper QRS voltage limits; S V3 shows the largest sex difference; gender adjustment required for Cornell voltage
• Race: African-Americans have higher upper normal QRS voltages → Sokolow-Lyon has higher sensitivity/lower specificity; Cornell shows lower sensitivity/higher specificity vs Euro-Americans; Hispanic-Americans have lower limits
• Obesity: Adipose tissue and increased heart-to-electrode distance reduce QRS voltage; Sokolow-Lyon less often positive in obese patients; Cornell voltage-duration product more often positive in obese patients; divergent behavior means obesity adjustments are criterion-specific
• (sources/ecg-chambers-aha-2009, rating: high)

LVH — QRS Duration and Conduction

• QRS duration increases with LVH due to increased LV wall thickness and intramural fibrosis
• In widened QRS LVH pattern: loss of septal Q wave; slurred R-wave upstroke; may be classified as incomplete LBBB (most commonly seen only in LVH)
• Progression from pure LVH voltage pattern → incomplete LBBB may be observed over time

LVH — Secondary ST-T Abnormality

• Preferred AHA terminology: "secondary ST-T abnormality" — the term "strain" is discouraged (as is "systolic overload" and "diastolic overload")
• Pattern: J-point depression; upwardly convex downsloping ST segment depression; asymmetric T-wave inversion in lateral leads (I, aVL, V5–V6)
• Mechanism: reversed APD gradient in hypertrophied LV (endocardial/epicardial reversal; intramural fibrosis); repolarization spreads from epicardium to endocardium rather than the normal direction
• Clinical significance: ST-T abnormalities in LVH are associated with larger LV mass and higher CV morbidity and mortality than voltage criteria alone (Framingham, LIFE data)
• ST-T abnormalities should be used as major supporting evidence for LVH, not as sole criteria
• Whether ST-T abnormalities should modify QRS voltage thresholds or permit LVH diagnosis in the absence of voltage criteria is an unresolved question
• (sources/ecg-chambers-aha-2009, rating: high)

LVH — Supporting Criteria (Not Diagnostic Alone)

• Left atrial P-wave abnormality: frequently present in hypertension; may be the earliest ECG sign of hypertensive heart disease; supporting criterion only
• Left axis deviation: may reflect hypertrophy, fascicular block, or age-related leftward axis shift; supporting criterion only
• QT prolongation: slight QT prolongation in LVH (secondary to QRS prolongation and altered ion channels); consistent with but not diagnostic of LVH

LVH in Conduction Disorders

LBBB:

• Studies conflicting; LVH diagnosis in pure LBBB should be approached with great caution
• High prevalence of anatomic LVH in LBBB patients (may be 90%+ at autopsy) distorts specificity estimates
• If criteria met: QRS duration >~155 ms + left atrial P-wave abnormality + precordial voltage criteria → reasonable to diagnose LVH despite low sensitivity
• Otherwise, avoid LVH diagnosis in LBBB

Left anterior fascicular block:

• Standard limb lead R-wave criteria (R I, R aVL) are unreliable; S-wave–based criteria in left precordial leads are preferred

RBBB:

• Reduces S-wave amplitude in right precordial leads → reduces standard criteria sensitivity
• Left atrial abnormality and left axis deviation have enhanced value; RBBB-specific criteria exist (see above table)

Right Ventricular Hypertrophy

ECG Performance by Disease

• Congenital heart disease: Highest accuracy
• Acquired disease / primary PAH: Intermediate accuracy
• COPD / chronic lung disease: Lowest accuracy
• Diagnosis requires right axis deviation + prominent anterior forces in right precordial leads in nearly all cases

Key Criteria (Table 2)

• R V1 ≥6 mm; R:S ratio V1 >1.0
• Deep S V5 ≥10 mm; deep S V6 ≥3 mm
• R aVR ≥4 mm; R V1 + S V5,6 ≥10.5 mm
• R-wave peak time V1 >0.035 s (QRS <120 ms); QR complex in V1
• Supporting: RSR' V1 (<120 ms); S>R in I, II, III; S I + Q III; negative T-wave V1–V3

RVH ECG patterns:

• Volume overload: incomplete RBBB-like; with right axis deviation + secondary ST-T changes
• Pressure overload: tall R waves (Rs, R, or Qr) in right precordial leads; right axis deviation + secondary ST-T changes

COPD ECG pattern (not true RVH): low voltage limb leads; rightward/superior/indeterminate QRS axis; P-wave axis >60°; persistent S waves in all precordial leads; low R V6 — RVH should only be suggested in this context if R V1 is relatively increased

(sources/ecg-chambers-aha-2009, rating: high)

Biventricular Hypertrophy

• Very low ECG sensitivity due to QRS vector cancellation between LV and RV
• Suspected when LVH criteria are met AND: prominent S V5/V6 + right axis deviation + tall biphasic R/S complexes in multiple leads + signs of right atrial abnormality
• In CHD with RVH: combined tall R + deep S in V2–V4 with combined amplitude >60 mm (6.0 mV) suggests LVH coexisting with RVH
• (sources/ecg-chambers-aha-2009, rating: high)

Atrial P-Wave Abnormalities — AHA 2009 Terminology

• Preferred terms: "left atrial abnormality" and "right atrial abnormality" — NOT enlargement, overload, strain, or hypertrophy
• "Intraatrial conduction delay" preferred over "interatrial" — delay typically involves Bachmann's bundle (a specialized pathway) and possibly left atrial myocardium; the anatomic distinction is often not determinable
• Multiple criteria should be applied; accuracy of combined atrial abnormality criteria is poorly established

Left Atrial Abnormality Criteria

• PTF-V1 (P terminal force in V1): product of amplitude × duration of terminal negative (left atrial) component in V1 — most frequently used criterion; PTF-V1 >40 mm·ms indicates abnormality
• P-wave duration ≥120 ms with notching ≥40 ms — equivalent value to PTF-V1
• Terminal P-wave axis −30 to −90°
• Purely negative P wave in V1: suggestive but insufficient alone
• P-wave widening ≥120 ms present in large majority of electrocardiographic LAA; reflects Bachmann's bundle delay
• (sources/ecg-chambers-aha-2009, rating: high)

Right Atrial Abnormality Criteria

• Tall P wave >2.5 mm in lead II: peaked/pointed (summation of enhanced right + simultaneous left atrial components)
• Prominent initial positivity in V1 or V2 ≥1.5 mm (0.15 mV): increased rightward/anterior initial P-wave forces
• Rightward P-wave axis + peaked form without increased amplitude: supporting signs
• Total P-wave duration usually normal (contrast with LAA)
• Exception: surgically repaired CHD with single-ventricle physiology → P-wave prolongation is a risk factor for atrial tachyarrhythmias

Left Atrial Abnormality vs Inter-Atrial Block (IAB)

• AHA 2009 "left atrial abnormality" encompasses what the ESC/HFA 2025 AtCM framework operationalizes as P-wave score contributions (PTF-V1 >40 mm·ms = score 1; partial IAB P ≥120 ms = score 1; advanced IAB P ≥120 ms + biphasic inferior leads = score 2)
• See concepts/Inter-Atrial-Block and concepts/Atrial-Cardiomyopathy for the contemporary disease framework built on these foundational criteria

Contradictions / Open Questions

• Sensitivity-specificity trade-off: No LVH criterion achieves both sensitivity >50% AND specificity >90% simultaneously; clinical utility depends heavily on pretest probability of the population tested
• Electrode misplacement effects on voltage criteria: AHA 2007 Part I documents that V1/V2 superior misplacement (2nd–3rd ICS) reduces amplitude ~0.1 mV per interspace and that V5/V6 inferior misplacement (6th ICS) alters LVH voltage criteria. Placement variation of as little as 2 cm can produce important diagnostic errors; computer-based LVH statements altered in up to 6% of recordings by misplacement. This means that Sokolow-Lyon and Cornell measurements are highly sensitive to electrode technique — a reproducibility limitation not reflected in their published performance data (sources/ecg-technology-aha-2007, rating: high)
• "Strain" terminology persistence: Despite AHA 2009 recommendation to discontinue "strain," the term remains in widespread clinical use and many published guidelines; the 2025 ESC AtCM framework uses "secondary ST-T changes" consistently with AHA 2009
• LVH in LBBB unresolved: AHA 2009 acknowledges conflicting evidence and recommends caution; no definitive resolution exists; high background LVH prevalence in LBBB continues to confound specificity calculations
• ECG vs imaging: Even by 2009 standards, 2D echocardiography had become the preferred reference standard; the clinical role of ECG LVH criteria is primarily screening and epidemiology, not diagnostic confirmation
• Posterior/lateral atrial abnormality classification: AHA 2009 favors "intraatrial" terminology, but whether Bachmann's bundle delay vs primary left atrial myocardial conduction disease can be distinguished by P-wave criteria remains unresolved

Connections

• Related to concepts/ST-T-Changes — secondary ST-T abnormality pattern in LVH; LVH mechanism section
• Related to concepts/Inter-Atrial-Block — IAB classification and P-wave scoring; AHA 2009 foundational criteria
• Related to concepts/ECG-Lead-Standards — electrode misplacement effects on voltage criteria; V5/V6 inferior and V1/V2 superior misplacement directly alter Sokolow-Lyon and Cornell measurements
• Related to concepts/Atrial-Cardiomyopathy — ESC 2025 P-wave scoring system built on these criteria
• Related to concepts/Cardiac-Repolarization — APD changes underlying LVH secondary ST-T changes
• Related to entities/HCM — concentric LVH patterns; overlap with HCM diagnosis
• Related to concepts/Pulmonary-Hypertension — RVH ECG patterns in PAH/CTEPH

Sources

• sources/ecg-chambers-aha-2009
• sources/ecg-technology-aha-2007